Association of serum leptin levels with progression of diabetic kidney disease in patients with type 2 diabetes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 21994433.
- Also identified by DOI 10.2337/dc11-1039 and PMC identifier 3220863.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To clarify the association of serum leptin levels with progression of diabetic kidney disease in patients with type 2 diabetes (T2D). This was an observational cohort study of 668 patients with T2D. Patients were classified into three groups by sex-specific tertile of leptin levels. Outcome measurements were the rate of change in estimated glomerular filtration rate (eGFR) and progression to a more advanced stage of albuminuria. Patients with low or high leptin levels had a steeper eGFR decline (-2.07 and -2.14 mL/min/1.73 m(2)/year) than those with midrange leptin levels (-0.82 mL/min/1.73 m(2)/year; P < 0.01), whereas patients with low leptin levels had an elevated risk of progression of albuminuria as compared with those with high leptin levels (hazard ratio 3.125 [95% CI 1.302-7.499]). Both low and high serum leptin levels were risk factors for kidney function decline. Meanwhile, lower serum leptin levels were associated with progression of albuminuria.
Medical subject headings
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Leptin